Tag: OnDemand
Data of Deucrictibant for the On-Demand Treatment of HAE Attacks Presented...
Posters highlight clinically meaningful improvement in HAE symptoms observed in the first hours after treatment with PHVS416 (deucrictibant immediate-release capsules) as compared to...
Positive Phase 2 Data from RAPIDe-1 Study of PHVS416 for the...
ZUG, Switzerland, March 18, 2023 (GLOBE NEWSWIRE) -- Pharvaris PHVS, a clinical-stage company developing novel, oral bradykinin-B2-receptor antagonists to treat and...